Hepatitis e virus: Seroprevalence and frequency of viral RNA detection among US blood donors

Transfusion

Volumn 56, Issue 2, 2016, Pages 481-488

  Stramer, Susan L ^a   Moritz, Erin D ^a   Foster, Gregory A ^a   Ong, Edgar ^b   Linnen, Jeffrey M ^b   Hogema, Boris M ^c   Mak, Matthew ^d   Chia, Chee Poh ^d   Dodd, Roger Y ^e  

^a AMERICAN RED CROSS   (United States)

^b HOLOGIC INC   (United States)

^c CENTRAL LABORATORY   (Netherlands)

^d MAGMA Engineering Asia Pacific Pte Ltd   (Singapore)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS RNA; VIRUS ANTIBODY;

ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN TISSUE; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; SEROPREVALENCE; UNITED STATES; VIRUS TRANSMISSION; ALGORITHM; BLOOD; DONOR SELECTION; FEMALE; MALE; PROCEDURES;

ALGORITHMS; ANTIBODIES, VIRAL; BLOOD DONORS; DONOR SELECTION; FEMALE; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES;

EID: 84958907056     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13355     Document Type: Article

References (32)

1. Hoofnagle JH, Nelson KE, Purcell RH., Hepatitis E. N Engl J Med 2012; 367: 1237-44.
2. Rein DB, Stevens GA, Theaker J, et al., The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012; 55: 988-97.
3. Stramer SL, Hollinger FB, Katz LM, et al., Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49 Suppl 2: 1S-29S. http://www.aabb.org/resources/bct/eid/Pages/default.aspx.
4. Stramer SL, Dodd RY., Transfusion-transmitted emerging infectious diseases: 30 years of challenges and progress. Transfusion 2013; 53: 2375-83.
5. Kamar N, Garrouste C, Haagsma EB, et al., Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-9.
6. Pas SD, de Man RA, Mulders C, et al., Hepatitis E virus infection among solid organ transplant recipients, the Netherlands. Emerg Infect Dis 2012; 18: 869-72.
7. Drobeniuc J, Greene-Montfort T, Le NT, et al., Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013; 19: 218-22.
8. Slot E, Hogema BM, Riezebos-Brillman A, et al., Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013; 18: pii: 20550.
9. Hogema BM, Molier M, Slot E, et al., Past and present of hepatitis E in the Netherlands. Transfusion 2014; 54: 3092-6.
10. Mansuy JM, Bendall R, Legrand-Abravanel F, et al., Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011; 17: 2309-12.
11. Xu C, Wang R, Schechterly C, et al., An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence of HEV transmission to 362 prospectively followed recipients. Transfusion 2013; 53: 2505-11.
12. Matsubayashi K, Nagaoka Y, Sakata H, et al., Transfusion-transmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004; 44: 934-40.
13. Mitsui T, Tsukamoto Y, Yamazaki C, et al., Prevalence of hepatitis E virus infection among hemodialysis patients in Japan: evidence for infection with a genotype 3 HEV by blood transfusion. J Med Virol 2004; 74: 563-72.
14. Tamura A, Shimizu YK, Tanaka T, et al., Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007; 37: 113-20.
15. Matsubayashi K, Kang JH, Sakata H, et al., A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route. Transfusion 2008; 48: 1368-75.
16. Boxall E, Herborn A, Kochethu G, et al., Transfusion transmitted hepatitis E in a "nonhyperendemic" country. Transfus Med 2006; 16: 79-83.
17. Hewitt PE, Ijaz S, Brailsford SR, et al., Hepatitis E virus in blood components: a prevalence and transmission study in southeast England. Lancet 2014; 384: 1766-73.
18. Colson P, Coze C, Gallian P, et al., Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007; 13: 648-9.
19. Khuroo MS, Kamili S, Yattoo GN., Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol 2004; 19: 778-84.
20. Hellstern P, Solheim BG., The use of solvent/detergent treatment in pathogen reduction of plasma. Transfus Med Hemother 2011; 38: 65-70.
21. Hauser L, Roque-Afonso AM, Beyloune A, et al., Hepatitis E transmission by transfusion of Intercept blood system-treated plasma. Blood 2014; 123: 796-7.
22. Sauleda S, Ong E, Bes M, et al., Seroprevalence of hepatitis E virus (HEV) and detection of HEV RNA with a transcription-mediated amplification assay in blood donors from Catalonia (Spain). Transfusion 2015; 55: 972-9.
23. Baylis SA, Blümel J, Mizusawa S, et al., World Health Organization International Standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis 2013; 19: 729-35.
24. Villalba MC, Guan M, Pérez A, et al., Seroprevalence of antibodies to hepatitis E virus in two large communities in Havana, Cuba. Trans R Soc Trop Med Hyg 2010; 104: 772-6.
25. Tian DY, Chen Y, Xia NS., Significance of serum IgA in patients with acute hepatitis E virus infection. World J Gastroenterol 2006; 12: 3919-23.
26. Hu WP, Lu Y, Precioso NA, et al., Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera. Clin Vacc Immunol 2008; 15: 1151-7.
27. Ditah I, Ditah F, Devaki P, et al., Current epidemiology of hepatitis E virus infection in the United States: low seroprevalence in the National Health and Nutrition Evaluation Survey. Hepatology 2014; 60: 815-22.
28. Herremans M, Duizer E, Jusic E, et al., Detection of hepatitis E virus-specific immunoglobulin a in patients infected with hepatitis E virus genotype 1 or 3. Clin Vacc Immunol 2007; 14: 276-80.
29. Holm DK, Moessner BK, Engle RE, et al., Declining prevalence of hepatitis E antibodies among Danish blood donors. Transfusion 2015; 55: 1662-7.
30. Fischer C, Hofmann M, Danzer M, et al., Seroprevalence and incidence of hepatitis E in blood donors in Upper Austria. PLoS One 2015; 10: e0119576.
31. Féray C, Pawlotsky JM, Roque-Afonso AM, et al., Should we screen blood products for hepatitis E virus RNA? Lancet 2014; 383: 218.
32. Pawlotsky JM., Hepatitis E screening for blood donations: an urgent need? Lancet 2014; 384: 1729-30.